KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Depreciation & Amortization (CF) (2020 - 2025)

Oscar Health (OSCR) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $7.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 14.57% year-over-year to $7.9 million, compared with a TTM value of $28.9 million through Dec 2025, down 10.09%, and an annual FY2025 reading of $28.9 million, down 10.09% over the prior year.
  • Depreciation & Amortization (CF) was $7.9 million for Q4 2025 at Oscar Health, up from $7.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $9.2 million in Q4 2024 and bottomed at $3.4 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $6.1 million, with a median of $6.8 million recorded in 2025.
  • The sharpest move saw Depreciation & Amortization (CF) soared 139.01% in 2023, then fell 18.4% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $4.0 million in 2021, then decreased by 5.37% to $3.8 million in 2022, then soared by 106.5% to $7.7 million in 2023, then grew by 19.17% to $9.2 million in 2024, then dropped by 14.57% to $7.9 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for OSCR at $7.9 million in Q4 2025, $7.3 million in Q3 2025, and $7.0 million in Q2 2025.